SCHEMBL30278755

SCHEMBL30278755

N#Cc1cccc(CNC(=O)C2(Sc3nnnn3-c3ccc(C(=O)O)cc3)CC2)c1

nearest known ligand 0.48

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 2/20 0.47
▸ MEN1 O00255 4/20 0.47
▸ KMT2A Q03164 4/20 0.47
▸ NPSR1 Q6W5P4 1/20 0.41
▸ MAPK1 P28482 3/20 0.40
▸ ALDH1A1 P00352 3/20 0.40
▸ PPARG P37231 1/20 0.40
▸ ATM Q13315 1/20 0.39
▸ MAOA P21397 1/20 0.39
▸ ERCC1 P07992 1/20 0.38
▸ ERCC4 Q92889 1/20 0.38
▸ TP53 P04637 1/20 0.38
▸ RARG P13631 1/20 0.38
▸ VNN1 O95497 1/20 0.37
▸ MMP13 P45452 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21952006 1.00 HPGD (0.47) HPGDMEN1KMT2ANPSR1MAPK1
SCHEMBL30278750 0.83 ALDH1A1 (0.48) HPGDMEN1KMT2ANPSR1ALDH1A1
SCHEMBL21952085 0.83 ALDH1A1 (0.48) HPGDMEN1KMT2ANPSR1ALDH1A1
SCHEMBL21952060 0.82 KMT2A (0.58) HPGDMEN1KMT2ANPSR1MAPK1
SCHEMBL31396269 0.82 KMT2A (0.58) HPGDMEN1KMT2ANPSR1MAPK1
SCHEMBL21952062 0.79 HPGD (0.47) HPGDMEN1KMT2ANPSR1MAPK1
SCHEMBL25610591 0.78 NR3C2 (0.38) MAOAERCC1ERCC4VNN1MMP13
SCHEMBL28676728 0.78 HPGD (0.53) HPGDMEN1KMT2ANPSR1MAPK1
SCHEMBL21952036 0.74 TSHR (0.42) HPGDMEN1KMT2ANPSR1MAPK1
SCHEMBL25609921 0.73 POLB (0.37) KMT2AMAPK1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115768422-B Ubiquitin ligase inhibitors for the treatment of cancer 诺沃亚桑托斯教授基金会 2025-03-04 — — CN disclosed
CN-115768422-A Ubiquitin ligase inhibitors for the treatment of cancer 诺沃亚桑托斯教授基金会 2023-03-07 — — CN disclosed
Send feedback